ANNEXON, INC. Shareholders' Equity
ANNEXON, INC. (ANNX) had Shareholders' Equity of $186.06 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $186.06M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $204.53M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $211.65M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $161.44M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $186.06M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $204.53M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $211.65M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $161.44M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $199.02M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $243.79M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $293.11M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | $331.56M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $361.08M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $262.40M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $250.56M 10-K · filed 2026-03-30 | |
| 2023-09-30 | $156.84M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $184.72M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $214.86M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $231.19M 10-K · filed 2025-03-03 | |
| 2022-09-30 | $260.60M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $168.04M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $200.61M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $231.91M 10-K · filed 2024-03-26 | |
| 2021-09-30 | $264.48M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $295.33M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $321.42M 10-Q · filed 2022-11-03 | $321.48M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $344.28M 10-K · filed 2023-03-06 | |
| 2020-09-30 | $365.48M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$117.87M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | -$112.42M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | -$100.45M 10-K · filed 2022-03-01 | |
| 2019-09-30 | -$91.76M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | -$81.89M 10-Q · filed 2020-11-16 | |
| 2019-03-31 | -$72.65M 10-Q · filed 2020-11-16 | |
| 2018-12-31 | -$64.20M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |